Blogroll
Dutch to cull mink at farms hit by coronavirus outbreak
The Dutch government on Wednesday ordered mink culled at nine farms where animals have been infected with the coronavirus, fearing they could form a reservoir of disease infecting humans after the country's current outbreak has passed.
Categories: Health
Malaria drug touted by Trump ineffective to prevent COVID-19 in high profile study
The malaria drug promoted by U.S. President Donald Trump as a treatment for COVID-19 was shown to be ineffective in preventing infection in people exposed to the coronavirus, according to a widely anticipated clinical trial released on Wednesday.
Categories: Health
Spain extends its state of emergency until June 21
The Spanish government on Wednesday secured parliament's backing for a final extension to the state of emergency imposed to tackle the coronavirus epidemic and which will now last until June 21.
Categories: Health
ZoomInfo looks to price IPO above target in 2020's largest tech listing so far: sources
ZoomInfo Technologies Inc is looking to price its initial public offering (IPO) on Wednesday above its upwardly revised target range in what is set to be the largest U.S. technology listing so far this year, people familiar with the matter said
Categories: Technology
France coronavirus death toll over 29,000, confirmed cases up
France's coronavirus death toll rose by 81 on Wednesday, or 0.3%, to reach 29,021, the fifth-highest death toll in the world, and the number of confirmed cases rose again after they went down Tuesday due to an adjustment in reporting.
Categories: Health
WHO set to resume hydroxychloroquine trial in battle against COVID-19
The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday, after those running the study briefly stopped giving it to new patients over health concerns.
Categories: Health
Germany bans digital doppelganger passport photos
Germany will outlaw the 'morphing' of passport photos, in which pictures of two people are digitally combined, making it possible to assign multiple identities to a single document.
Categories: Technology
Apple must face U.S. shareholder lawsuit over CEO's iPhone, China comments
A federal judge said Apple Inc must face part of a lawsuit claiming it fraudulently concealed falling demand for iPhones, especially in China, leading to tens of billions of dollars in shareholder losses.
Categories: Technology
Brazil health regulator approves clinical trials of Oxford COVID-19 vaccine
Brazil's health regulator Anvisa has approved human clinical trials for a potential coronavirus vaccine developed by scientists at Oxford University and supported by AstraZeneca Plc, it said on Wednesday.
Categories: Health
U.S. CDC reports 1,827,425 coronavirus cases
The U.S. Centers for Disease Control and Prevention (CDC) on Wednesday reported 1,827,425 cases of new coronavirus, an increase of 24,955 cases from its previous count, and said the number of deaths had risen by 1,045 to 106,202.
Categories: Health
Mexico's COVID-19 death toll could surpass 30,000: deputy health minister
Mexico's death toll from the coronavirus pandemic may reach 30,000, a senior health official said in a newspaper interview published on Wednesday, while suggesting fatalities could be even higher if social distancing measures were relaxed too fast.
Categories: Health
Sharp decline in emergency visits seen in early days of coronavirus pandemic: U.S. study
Emergency department visits fell 42% across the United States during the early days of the coronavirus pandemic compared to the same period last year, according to a study by the U.S. Centers for Disease Control and Prevention (CDC).
Categories: Health
Hackers and hucksters reinvigorate 'Anonymous' brand amid protests
The amorphous internet activist movement known as Anonymous staged an online resurgence in the past week on the back of real-world protests against police brutality.
Categories: Technology
Gilead's remdesivir could see $7 billion in annual sales on stockpiling boost: analyst
Gilead Sciences Inc's potential COVID-19 treatment, remdesivir, could bring in more than $7 billion in annual sales by 2022, spurred by governments stockpiling the drug to guard against future outbreaks, SVB Leerink said on Wednesday.
Categories: Health
Vaccine group plans advance market agreement for COVID-19 vaccines
The GAVI vaccines alliance is to launch an Advance Market Commitment (AMC) for future COVID-19 vaccines which it says will help secure access to the new shots for poorer countries.
Categories: Health
Sanofi to run consultations over restart of hydroxychloroquine trials
Sanofi said on Wednesday it would review available information and run consultations before deciding whether to enroll patients again for its COVID-19-related hydroxychloroquine trials.
Categories: Health
WHO set to resume hydroxychloroquine trial in battle on COVID-19
The World Health Organization (WHO) is set to resume its trial of hydroxychloroquine for potential use against the new coronavirus, its head Tedros Adhanom Ghebreyesus said on Wednesday, after testing was suspended due to health concerns.
Categories: Health
Global smartphone shipments to fall 12% this year on virus woes: IDC
Global smartphone shipments will fall nearly 12% to 1.2 billion units in 2020, market research firm IDC said on Wednesday, citing lower consumer spending due to the economic impact of the coronavirus crisis.
Categories: Technology
Spain reports first new COVID-19 death since Sunday
Spain on Wednesday reported its first death from the coronavirus since Sunday as the government sought parliament's backing for a final extension to the country's state of emergency.
Categories: Health
UK PM Johnson promises COVID-19 test results within 24 hours by end of month
The results of almost all tests for the coronavirus should be available within 24 hours by the end of this month, British Prime Minister Boris Johnson said on Wednesday.
Categories: Health


